| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 08, 2026 |
enGene Holdings Inc
ENGN
|
BUY |
$4.00
Est. +133%
|
$1.72 | $1.87 |
Pending
|
$1.62
-5.8%
|
| Mar 04, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$58.00
Est. +29%
|
$44.85 | $52.19 |
Pending
|
$44.18
-1.5%
|
| Feb 06, 2026 |
Incyte Corp.
INCY
|
BUY |
$110.00
Est. +7%
|
$102.76 | $110.34 |
Bullseye Hit (±1%)
|
$108.53
+5.6%
|
| Feb 06, 2026 |
Akebia Therapeutics Inc.
AKBA
|
BUY |
$4.00
Est. +190%
|
$1.38 | $1.60 |
Pending
|
$0.92
-33.0%
|
| Nov 04, 2025 |
Incyte Corp.
INCY
|
SELL |
$102.00
Est. +0%
|
$102.35 | $89.25 (Low) |
Target Met
|
$108.53
-6.0%
|
| Sep 24, 2025 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$51.00
Est. +51%
|
$33.75 | $52.19 |
Precision Hit (±3%)
|
$44.18
+30.9%
|
| May 16, 2025 |
Inozyme Pharma Inc
INZY
|
BUY |
$4.00
Est. +1%
|
$3.95 | $4.00 |
Bullseye Hit (±1%)
|
$4.00
+1.3%
|
| Oct 15, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$42.00
Est. +47%
|
$28.52 | $46.98 |
Target Met
|
$44.18
+54.9%
|
| May 31, 2024 |
Roivant Sciences Ltd
ROIV
|
BUY |
$20.00
Est. +92%
|
$10.39 | $13.06 |
Miss
|
$30.04
+189.1%
|
| May 23, 2024 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$28.00
Est. +150%
|
$11.18 | $46.98 |
Target Met
|
$44.18
+295.2%
|
| Apr 02, 2024 |
Q32 Bio Inc.
QTTB
|
BUY |
$45.00
Est. +150%
|
$18.00 | $53.73 |
Target Met
|
$12.64
-29.8%
|